Dr. Patricia Kim

Dr. Kim specializes in minimal residual disease (MRD) monitoring and precision medicine approaches for leukemia. Her research develops advanced methods for detecting even tiny amounts of remaining leukemia, enabling earlier intervention and more precise treatment decisions. She leads innovative studies exploring next-generation MRD detection methods including liquid biopsies that could make monitoring less invasive. Her work helps identify patients at risk of relapse earlier, potentially improving outcomes across all leukemia types.